Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometrial Neoplasms | 7 | 2024 | 1365 | 1.010 |
Why?
|
DNA Mismatch Repair | 3 | 2024 | 428 | 0.830 |
Why?
|
Brachytherapy | 5 | 2024 | 1223 | 0.690 |
Why?
|
Sex Reassignment Surgery | 1 | 2023 | 164 | 0.690 |
Why?
|
Rectal Neoplasms | 2 | 2014 | 1156 | 0.490 |
Why?
|
Nose Neoplasms | 1 | 2016 | 249 | 0.440 |
Why?
|
Fat Necrosis | 1 | 2013 | 60 | 0.430 |
Why?
|
Neoplasm Staging | 14 | 2024 | 11118 | 0.430 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2022 | 2020 | 0.410 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2022 | 9277 | 0.310 |
Why?
|
Adenocarcinoma | 4 | 2014 | 6345 | 0.300 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2014 | 2057 | 0.300 |
Why?
|
Urinalysis | 1 | 2009 | 368 | 0.280 |
Why?
|
Vagina | 2 | 2023 | 841 | 0.280 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2013 | 1372 | 0.250 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4110 | 0.250 |
Why?
|
Lymph Nodes | 5 | 2023 | 3461 | 0.250 |
Why?
|
Colonic Neoplasms | 2 | 2014 | 2533 | 0.240 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2020 | 4021 | 0.240 |
Why?
|
Metabolic Networks and Pathways | 1 | 2009 | 789 | 0.240 |
Why?
|
Breast | 1 | 2013 | 1963 | 0.230 |
Why?
|
Hysterectomy | 2 | 2020 | 856 | 0.220 |
Why?
|
Adenomatous Polyposis Coli Protein | 2 | 2014 | 180 | 0.210 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2827 | 0.210 |
Why?
|
GTP Phosphohydrolases | 3 | 2014 | 517 | 0.200 |
Why?
|
Proto-Oncogene Proteins | 3 | 2014 | 4512 | 0.200 |
Why?
|
Carcinoma, Endometrioid | 2 | 2024 | 276 | 0.190 |
Why?
|
Kaplan-Meier Estimate | 7 | 2024 | 6473 | 0.190 |
Why?
|
Anal Canal | 1 | 2023 | 374 | 0.180 |
Why?
|
Radiotherapy, Adjuvant | 5 | 2024 | 1784 | 0.170 |
Why?
|
Age Factors | 3 | 2013 | 18381 | 0.170 |
Why?
|
Lymph Node Excision | 2 | 2022 | 1269 | 0.160 |
Why?
|
Radiotherapy Dosage | 3 | 2016 | 2897 | 0.160 |
Why?
|
Enzyme Inhibitors | 2 | 2009 | 3705 | 0.160 |
Why?
|
Glioblastoma | 2 | 2015 | 3481 | 0.150 |
Why?
|
Proportional Hazards Models | 5 | 2024 | 12448 | 0.150 |
Why?
|
Prostatic Neoplasms | 2 | 2012 | 11107 | 0.150 |
Why?
|
Vulvar Neoplasms | 1 | 2020 | 263 | 0.150 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2017 | 65 | 0.140 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2023 | 3514 | 0.140 |
Why?
|
Smoking | 3 | 2016 | 9054 | 0.130 |
Why?
|
Retrospective Studies | 13 | 2024 | 80583 | 0.130 |
Why?
|
Disease-Free Survival | 4 | 2024 | 6807 | 0.130 |
Why?
|
Female | 27 | 2024 | 392203 | 0.130 |
Why?
|
Karnofsky Performance Status | 1 | 2016 | 166 | 0.130 |
Why?
|
Gene Amplification | 1 | 2020 | 1087 | 0.130 |
Why?
|
Lymphatic Irradiation | 1 | 2016 | 115 | 0.130 |
Why?
|
DNA Methylation | 3 | 2014 | 4392 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2015 | 2916 | 0.120 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2017 | 258 | 0.120 |
Why?
|
Brain Neoplasms | 3 | 2015 | 9026 | 0.120 |
Why?
|
Relative Biological Effectiveness | 1 | 2016 | 311 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11735 | 0.120 |
Why?
|
Cecal Neoplasms | 1 | 2014 | 26 | 0.120 |
Why?
|
Neoplasms | 1 | 2023 | 22131 | 0.110 |
Why?
|
Radiotherapy | 2 | 2013 | 1497 | 0.110 |
Why?
|
Community Health Centers | 1 | 2017 | 460 | 0.110 |
Why?
|
Aged | 16 | 2024 | 169092 | 0.110 |
Why?
|
Middle Aged | 18 | 2024 | 220603 | 0.110 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2016 | 242 | 0.110 |
Why?
|
Colon, Sigmoid | 1 | 2014 | 124 | 0.110 |
Why?
|
Pelvis | 1 | 2017 | 732 | 0.110 |
Why?
|
Humans | 33 | 2024 | 760740 | 0.100 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2014 | 899 | 0.100 |
Why?
|
Survival Rate | 3 | 2017 | 12719 | 0.100 |
Why?
|
Mutation | 2 | 2015 | 30015 | 0.100 |
Why?
|
Tumor Burden | 3 | 2015 | 1892 | 0.100 |
Why?
|
Breast Neoplasms | 4 | 2015 | 20988 | 0.100 |
Why?
|
Aged, 80 and over | 8 | 2016 | 58919 | 0.100 |
Why?
|
Radiography | 2 | 2013 | 6961 | 0.100 |
Why?
|
Organs at Risk | 1 | 2014 | 359 | 0.100 |
Why?
|
ras Proteins | 2 | 2014 | 1054 | 0.100 |
Why?
|
Mastectomy, Segmental | 2 | 2015 | 955 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2020 | 571 | 0.100 |
Why?
|
Radiation Oncology | 1 | 2017 | 563 | 0.090 |
Why?
|
Carcinoma, Lobular | 1 | 2015 | 480 | 0.090 |
Why?
|
Microsatellite Instability | 1 | 2014 | 716 | 0.090 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2013 | 237 | 0.090 |
Why?
|
Stomach Neoplasms | 1 | 2020 | 1459 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2020 | 1657 | 0.090 |
Why?
|
DNA-Binding Proteins | 3 | 2022 | 9586 | 0.080 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2005 | 5319 | 0.080 |
Why?
|
Organophosphorus Compounds | 1 | 2010 | 206 | 0.080 |
Why?
|
Membrane Proteins | 4 | 2014 | 7847 | 0.080 |
Why?
|
Deoxycytidine | 1 | 2014 | 878 | 0.080 |
Why?
|
Rectum | 1 | 2014 | 891 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 1745 | 0.080 |
Why?
|
Comet Assay | 1 | 2009 | 75 | 0.080 |
Why?
|
Adult | 13 | 2020 | 220995 | 0.080 |
Why?
|
Fluorouracil | 1 | 2014 | 1642 | 0.080 |
Why?
|
Genital Neoplasms, Female | 1 | 2014 | 532 | 0.080 |
Why?
|
Prognosis | 5 | 2024 | 29601 | 0.080 |
Why?
|
Bone Marrow Diseases | 1 | 2010 | 233 | 0.080 |
Why?
|
Lymphoma, Follicular | 1 | 2013 | 457 | 0.080 |
Why?
|
Radiation Injuries | 1 | 2016 | 1189 | 0.080 |
Why?
|
Receptors, Growth Factor | 1 | 2009 | 326 | 0.080 |
Why?
|
Male | 15 | 2023 | 360402 | 0.080 |
Why?
|
Neoplasm, Residual | 1 | 2013 | 1008 | 0.080 |
Why?
|
Urinary Bladder | 1 | 2014 | 1151 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2014 | 2863 | 0.070 |
Why?
|
Electric Countershock | 1 | 2010 | 532 | 0.070 |
Why?
|
Organometallic Compounds | 1 | 2010 | 646 | 0.070 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2009 | 426 | 0.070 |
Why?
|
Physical Examination | 1 | 2013 | 1254 | 0.070 |
Why?
|
Promoter Regions, Genetic | 3 | 2014 | 5780 | 0.070 |
Why?
|
Treatment Failure | 1 | 2013 | 2635 | 0.070 |
Why?
|
Genotype | 4 | 2015 | 12977 | 0.070 |
Why?
|
Edema | 1 | 2010 | 765 | 0.070 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2009 | 506 | 0.070 |
Why?
|
Hydroxamic Acids | 1 | 2009 | 481 | 0.070 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 2020 | 0.070 |
Why?
|
Colonoscopy | 1 | 2014 | 1397 | 0.060 |
Why?
|
Dacarbazine | 1 | 2009 | 559 | 0.060 |
Why?
|
Smad8 Protein | 1 | 2005 | 17 | 0.060 |
Why?
|
Age of Onset | 1 | 2012 | 3303 | 0.060 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2005 | 83 | 0.060 |
Why?
|
Glutathione S-Transferase pi | 1 | 2005 | 99 | 0.060 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2010 | 709 | 0.060 |
Why?
|
Alprostadil | 1 | 2004 | 86 | 0.060 |
Why?
|
Bronchi | 2 | 2005 | 846 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2014 | 8542 | 0.060 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2005 | 489 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2005 | 13383 | 0.060 |
Why?
|
Mitosis | 1 | 2009 | 1187 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2896 | 0.050 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2005 | 263 | 0.050 |
Why?
|
Isoenzymes | 2 | 2005 | 1687 | 0.050 |
Why?
|
Adenoma | 1 | 2014 | 2159 | 0.050 |
Why?
|
Glutathione Transferase | 1 | 2005 | 565 | 0.050 |
Why?
|
Chromosomes, Human | 1 | 2005 | 441 | 0.050 |
Why?
|
Regression Analysis | 1 | 2012 | 6339 | 0.050 |
Why?
|
DNA, Neoplasm | 2 | 2005 | 1743 | 0.050 |
Why?
|
Prostate-Specific Antigen | 1 | 2012 | 2465 | 0.050 |
Why?
|
Loss of Heterozygosity | 1 | 2005 | 662 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3798 | 0.050 |
Why?
|
Cause of Death | 1 | 2012 | 3683 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2005 | 697 | 0.050 |
Why?
|
Respiratory Mucosa | 1 | 2005 | 438 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2022 | 64572 | 0.050 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6126 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2013 | 1639 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39062 | 0.050 |
Why?
|
ROC Curve | 1 | 2009 | 3575 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9417 | 0.050 |
Why?
|
Defibrillators, Implantable | 1 | 2010 | 1483 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2009 | 3599 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 1 | 2005 | 829 | 0.050 |
Why?
|
Cadherins | 1 | 2005 | 901 | 0.040 |
Why?
|
Ultrasonography | 1 | 2013 | 5965 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3593 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2005 | 1022 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 1135 | 0.040 |
Why?
|
DNA Repair | 1 | 2009 | 2043 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5789 | 0.040 |
Why?
|
Risk Factors | 4 | 2015 | 74128 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2009 | 4910 | 0.040 |
Why?
|
Esophagogastric Junction | 1 | 2020 | 347 | 0.040 |
Why?
|
Bone Neoplasms | 1 | 2010 | 2527 | 0.040 |
Why?
|
Precancerous Conditions | 1 | 2005 | 982 | 0.040 |
Why?
|
Endometrium | 1 | 2020 | 403 | 0.040 |
Why?
|
Rh Isoimmunization | 1 | 2017 | 23 | 0.040 |
Why?
|
Heart Diseases | 1 | 2010 | 2778 | 0.040 |
Why?
|
Reperfusion Injury | 1 | 2004 | 1023 | 0.040 |
Why?
|
Salpingectomy | 1 | 2017 | 44 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2017 | 8516 | 0.030 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2020 | 732 | 0.030 |
Why?
|
Apoptosis | 2 | 2009 | 9476 | 0.030 |
Why?
|
Quality of Life | 1 | 2017 | 13359 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 6074 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12661 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2009 | 16968 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2851 | 0.030 |
Why?
|
Ovariectomy | 1 | 2017 | 613 | 0.030 |
Why?
|
Colon, Ascending | 1 | 2014 | 14 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2020 | 2509 | 0.030 |
Why?
|
Cisplatin | 1 | 2020 | 1650 | 0.030 |
Why?
|
Proteins | 1 | 2009 | 6030 | 0.030 |
Why?
|
Time Factors | 4 | 2021 | 39908 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2015 | 473 | 0.030 |
Why?
|
MutS Homolog 2 Protein | 1 | 2014 | 197 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2009 | 10429 | 0.030 |
Why?
|
Young Adult | 3 | 2015 | 59191 | 0.030 |
Why?
|
Retreatment | 1 | 2015 | 596 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2005 | 4408 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2014 | 346 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 5838 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2004 | 4433 | 0.020 |
Why?
|
Disease Progression | 2 | 2005 | 13495 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20556 | 0.020 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2014 | 380 | 0.020 |
Why?
|
Adenosine Triphosphatases | 1 | 2014 | 835 | 0.020 |
Why?
|
Mitotic Index | 1 | 2009 | 162 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1113 | 0.020 |
Why?
|
Colonic Polyps | 1 | 2014 | 553 | 0.020 |
Why?
|
Adolescent | 2 | 2015 | 88247 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2015 | 937 | 0.020 |
Why?
|
Models, Biological | 1 | 2005 | 9461 | 0.020 |
Why?
|
Cesarean Section | 1 | 2017 | 1396 | 0.020 |
Why?
|
Equipment Failure | 1 | 2010 | 577 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2607 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8835 | 0.020 |
Why?
|
Acetylation | 1 | 2009 | 1055 | 0.020 |
Why?
|
Schizophrenia | 1 | 2005 | 6929 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 1646 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 36401 | 0.020 |
Why?
|
Dermatoglyphics | 1 | 2005 | 20 | 0.020 |
Why?
|
Leg | 1 | 2010 | 1087 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 23974 | 0.020 |
Why?
|
Mice | 2 | 2009 | 81368 | 0.020 |
Why?
|
Immunotherapy | 1 | 2020 | 4642 | 0.010 |
Why?
|
Histone Deacetylases | 1 | 2009 | 719 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3410 | 0.010 |
Why?
|
Cyclooxygenase 1 | 1 | 2004 | 97 | 0.010 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2009 | 774 | 0.010 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 318 | 0.010 |
Why?
|
Mice, Nude | 1 | 2009 | 3606 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2005 | 783 | 0.010 |
Why?
|
Equipment Design | 1 | 2010 | 3501 | 0.010 |
Why?
|
Leukocytes | 1 | 2010 | 2024 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2004 | 596 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 2005 | 733 | 0.010 |
Why?
|
Dinoprostone | 1 | 2004 | 597 | 0.010 |
Why?
|
Cell Cycle | 1 | 2009 | 2929 | 0.010 |
Why?
|
CpG Islands | 1 | 2005 | 1192 | 0.010 |
Why?
|
Bone Marrow | 1 | 2010 | 2909 | 0.010 |
Why?
|
Animals | 2 | 2009 | 168202 | 0.010 |
Why?
|
Blood Platelets | 1 | 2010 | 2478 | 0.010 |
Why?
|
Microcirculation | 1 | 2004 | 1272 | 0.010 |
Why?
|
Lactic Acid | 1 | 2004 | 1139 | 0.010 |
Why?
|
Histones | 1 | 2009 | 2577 | 0.010 |
Why?
|
Brain | 1 | 2005 | 27100 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4569 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 29869 | 0.010 |
Why?
|
RNA | 1 | 2005 | 2713 | 0.010 |
Why?
|
Cell Survival | 1 | 2004 | 5780 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2005 | 4739 | 0.010 |
Why?
|
Base Sequence | 1 | 2005 | 12420 | 0.010 |
Why?
|
Alleles | 1 | 2005 | 6861 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 10203 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2005 | 3672 | 0.010 |
Why?
|
Infant | 1 | 2015 | 36157 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2005 | 17630 | 0.010 |
Why?
|
Gene Expression | 1 | 2005 | 7569 | 0.010 |
Why?
|
Child, Preschool | 1 | 2015 | 42193 | 0.010 |
Why?
|
DNA | 1 | 2005 | 7196 | 0.010 |
Why?
|
Skin | 1 | 2004 | 4472 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 54364 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 15577 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2004 | 12759 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2005 | 22153 | 0.000 |
Why?
|
Child | 1 | 2015 | 80089 | 0.000 |
Why?
|